Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2001 Oct;85(8):1201–1205. doi: 10.1054/bjoc.2001.2062

Frequent somatic loss of BRCA1 in breast tumours from BRCA2 germ-line mutation carriers and vice versa

S Staff 1, J J Isola 1, O Johannsson 2, Å Borg 2, M M Tanner 1
PMCID: PMC2375151  PMID: 11710835

Abstract

Breast cancer susceptibility genes BRCA1 and BRCA2 are tumour suppressor genes the alleles of which have to be inactivated before tumour development occurs. Hereditary breast cancers linked to germ-line mutations of BRCA1 and BRCA2 genes almost invariably show allelic imbalance (AI) at the respective loci. BRCA1 and BRCA2 are believed to take part in a common pathway in maintenance of genomic integrity in cells. We carried out AI and fluorescence in situ hybridization (FISH) analyses of BRCA2 in breast tumours from germ-line BRCA1 mutation carriers and vice versa. For comparison, 14 sporadic breast tumours were also studied. 8 of the 11 (73%) informative BRCA1 mutation tumours showed AI at the BRCA2 locus. 53% of these tumours showed a copy number loss of the BRCA2 gene by FISH. 5 of the 6 (83%) informative BRCA2 mutation tumours showed AI at the BRCA1 locus. Half of the tumours (4/8) showed a physical deletion of the BRCA1 gene by FISH. Combined allelic loss of both BRCA1 and BRCA2 gene was seen in 12 of the 17 (71%) informative hereditary tumours, whereas copy number losses of both BRCA genes was seen in only 4/14 (29%) sporadic control tumours studied by FISH. In conclusion, the high prevalence of AI at BRCA1 in BRCA2 mutation tumours and vice versa suggests that somatic events occurring at the other breast cancer susceptibility gene locus may be selected in the cancer development. The mechanism resulting in AI at these loci seems more complex than a physical deletion.   http://www.bjcancer.com © 2001 Cancer Research Campaign

Keywords: BRCA1, BRCA2, allelic imbalance, LOH, FISH

Full Text

The Full Text of this article is available as a PDF (171.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albertsen H. M., Smith S. A., Mazoyer S., Fujimoto E., Stevens J., Williams B., Rodriguez P., Cropp C. S., Slijepcevic P., Carlson M. A physical map and candidate genes in the BRCA1 region on chromosome 17q12-21. Nat Genet. 1994 Aug;7(4):472–479. doi: 10.1038/ng0894-472. [DOI] [PubMed] [Google Scholar]
  2. Beckmann M. W., Picard F., An H. X., van Roeyen C. R., Dominik S. I., Mosny D. S., Schnürch H. G., Bender H. G., Niederacher D. Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancer. Br J Cancer. 1996 May;73(10):1220–1226. doi: 10.1038/bjc.1996.234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bièche I., Noguès C., Rivoilan S., Khodja A., Latil A., Lidereau R. Prognostic value of loss of heterozygosity at BRCA2 in human breast carcinoma. Br J Cancer. 1997;76(11):1416–1418. doi: 10.1038/bjc.1997.572. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Collins N., McManus R., Wooster R., Mangion J., Seal S., Lakhani S. R., Ormiston W., Daly P. A., Ford D., Easton D. F. Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13. Oncogene. 1995 Apr 20;10(8):1673–1675. [PubMed] [Google Scholar]
  5. Gudmundsson J., Johannesdottir G., Bergthorsson J. T., Arason A., Ingvarsson S., Egilsson V., Barkardottir R. B. Different tumor types from BRCA2 carriers show wild-type chromosome deletions on 13q12-q13. Cancer Res. 1995 Nov 1;55(21):4830–4832. [PubMed] [Google Scholar]
  6. Gyapay G., Morissette J., Vignal A., Dib C., Fizames C., Millasseau P., Marc S., Bernardi G., Lathrop M., Weissenbach J. The 1993-94 Généthon human genetic linkage map. Nat Genet. 1994 Jun;7(2 Spec No):246–339. doi: 10.1038/ng0694supp-246. [DOI] [PubMed] [Google Scholar]
  7. Hamann U., Herbold C., Costa S., Solomayer E. F., Kaufmann M., Bastert G., Ulmer H. U., Frenzel H., Komitowski D. Allelic imbalance on chromosome 13q: evidence for the involvement of BRCA2 and RB1 in sporadic breast cancer. Cancer Res. 1996 May 1;56(9):1988–1990. [PubMed] [Google Scholar]
  8. Håkansson S., Johannsson O., Johansson U., Sellberg G., Loman N., Gerdes A. M., Holmberg E., Dahl N., Pandis N., Kristoffersson U. Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer. Am J Hum Genet. 1997 May;60(5):1068–1078. [PMC free article] [PubMed] [Google Scholar]
  9. Johannsson O., Ostermeyer E. A., Håkansson S., Friedman L. S., Johansson U., Sellberg G., Brøndum-Nielsen K., Sele V., Olsson H., King M. C. Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden. Am J Hum Genet. 1996 Mar;58(3):441–450. [PMC free article] [PubMed] [Google Scholar]
  10. Kelsell D. P., Spurr N. K., Barnes D. M., Gusterson B., Bishop D. T. Combined loss of BRCA1/BRCA2 in grade 3 breast carcinomas. Lancet. 1996 Jun 1;347(9014):1554–1555. doi: 10.1016/s0140-6736(96)90707-2. [DOI] [PubMed] [Google Scholar]
  11. Kerangueven F., Noguchi T., Coulier F., Allione F., Wargniez V., Simony-Lafontaine J., Longy M., Jacquemier J., Sobol H., Eisinger F. Genome-wide search for loss of heterozygosity shows extensive genetic diversity of human breast carcinomas. Cancer Res. 1997 Dec 15;57(24):5469–5474. [PubMed] [Google Scholar]
  12. Miki Y., Swensen J., Shattuck-Eidens D., Futreal P. A., Harshman K., Tavtigian S., Liu Q., Cochran C., Bennett L. M., Ding W. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994 Oct 7;266(5182):66–71. doi: 10.1126/science.7545954. [DOI] [PubMed] [Google Scholar]
  13. Nagai M. A., Yamamoto L., Salaorni S., Pacheco M. M., Brentani M. M., Barbosa E. M., Brentani R. R., Mazoyer S., Smith S. A., Ponder B. A. Detailed deletion mapping of chromosome segment 17q12-21 in sporadic breast tumours. Genes Chromosomes Cancer. 1994 Sep;11(1):58–62. doi: 10.1002/gcc.2870110109. [DOI] [PubMed] [Google Scholar]
  14. Neuhausen S. L., Marshall C. J. Loss of heterozygosity in familial tumors from three BRCA1-linked kindreds. Cancer Res. 1994 Dec 1;54(23):6069–6072. [PubMed] [Google Scholar]
  15. Niederacher D., Picard F., van Roeyen C., An H. X., Bender H. G., Beckmann M. W. Patterns of allelic loss on chromosome 17 in sporadic breast carcinomas detected by fluorescent-labeled microsatellite analysis. Genes Chromosomes Cancer. 1997 Mar;18(3):181–192. doi: 10.1002/(sici)1098-2264(199703)18:3<181::aid-gcc5>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  16. Phelan C. M., Borg A., Cuny M., Crichton D. N., Baldersson T., Andersen T. I., Caligo M. A., Lidereau R., Lindblom A., Seitz S. Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters. Cancer Res. 1998 Mar 1;58(5):1004–1012. [PubMed] [Google Scholar]
  17. Silva J. M., Gonzalez R., Provencio M., Dominguez G., Garcia J. M., Gallego I., Palacios J., España P., Bonilla F. Loss of heterozygosity in BRCA1 and BRCA2 markers and high-grade malignancy in breast cancer. Breast Cancer Res Treat. 1999 Jan;53(1):9–17. doi: 10.1023/a:1006082117266. [DOI] [PubMed] [Google Scholar]
  18. Smith S. A., Easton D. F., Evans D. G., Ponder B. A. Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome. Nat Genet. 1992 Oct;2(2):128–131. doi: 10.1038/ng1092-128. [DOI] [PubMed] [Google Scholar]
  19. Staff S., Nupponen N. N., Borg A., Isola J. J., Tanner M. M. Multiple copies of mutant BRCA1 and BRCA2 alleles in breast tumors from germ-line mutation carriers. Genes Chromosomes Cancer. 2000 Aug;28(4):432–442. doi: 10.1002/1098-2264(200008)28:4<432::aid-gcc9>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  20. Szabo C. I., King M. C. Population genetics of BRCA1 and BRCA2. Am J Hum Genet. 1997 May;60(5):1013–1020. [PMC free article] [PubMed] [Google Scholar]
  21. Tanner M. M., Karhu R. A., Nupponen N. N., Borg A., Baldetorp B., Pejovic T., Fernö M., Killander D., Isola J. J. Genetic aberrations in hypodiploid breast cancer: frequent loss of chromosome 4 and amplification of cyclin D1 oncogene. Am J Pathol. 1998 Jul;153(1):191–199. doi: 10.1016/S0002-9440(10)65560-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Tavtigian S. V., Simard J., Rommens J., Couch F., Shattuck-Eidens D., Neuhausen S., Merajver S., Thorlacius S., Offit K., Stoppa-Lyonnet D. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet. 1996 Mar;12(3):333–337. doi: 10.1038/ng0396-333. [DOI] [PubMed] [Google Scholar]
  23. Welcsh P. L., Owens K. N., King M. C. Insights into the functions of BRCA1 and BRCA2. Trends Genet. 2000 Feb;16(2):69–74. doi: 10.1016/s0168-9525(99)01930-7. [DOI] [PubMed] [Google Scholar]
  24. Wooster R., Neuhausen S. L., Mangion J., Quirk Y., Ford D., Collins N., Nguyen K., Seal S., Tran T., Averill D. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science. 1994 Sep 30;265(5181):2088–2090. doi: 10.1126/science.8091231. [DOI] [PubMed] [Google Scholar]
  25. van den Berg J., Johannsson O., Håkansson S., Olsson H., Borg A. Allelic loss at chromosome 13q12-q13 is associated with poor prognosis in familial and sporadic breast cancer. Br J Cancer. 1996 Nov;74(10):1615–1619. doi: 10.1038/bjc.1996.597. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES